ALKEM · Alkem Laboratories Limited · Financials
Volume · Nov 13
17.66K
Avg daily vol (3M)
16.89K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
147.12B
+13.5%
FY2026
Net Income
23.02B
+6.3%
FY2026
Operating Cash Flow
19.63B
+2.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| INR | 156.32B | 147.12B | 129.65B | 126.68B | 115.99B | 106.34B | 83.44B | 73.57B | 64.31B |
| INR | 4.38B | 3.82B | 3.57B | 2.99B | 3.1B | 3.04B | 2.53B | 1.93B | 1.43B |
| INR | 2B | 1.61B | 1.22B | 1.12B | 1.07B | 523.7M | 650.6M | 546.3M | 553.3M |
| INR | — | — | — | 20.23B | 13.05B | 18.44B | 12.6B | 9.55B | 9.26B |
| INR | 8.81B | 5.18B | 3.11B | 2.12B | 2.98B | 1.64B | 1.1B | 1.81B | 2.88B |
| INR | 20.68B | 23.02B | 21.65B | 17.96B | 9.84B | 16.46B | 11.27B | 7.61B | 6.31B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 26.1B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.